NEOLEUKIN THERAPEUTICS INC - COM (NLTX)

CUSIP: 64049K104

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / COM
Total 13F shares
20,796,660
Share change
-3,655,424
Total reported value
$21,420,000
Price per share
$1.03
Number of holders
53
Value change
-$4,503,223
Number of buys
25
Number of sells
50

Quarterly Holders Quick Answers

What is CUSIP 64049K104?
CUSIP 64049K104 identifies NLTX - NEOLEUKIN THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEOLEUKIN THERAPEUTICS INC - COM (NLTX) as of Q2 2022

As of 30 Jun 2022, NEOLEUKIN THERAPEUTICS INC - COM (NLTX) was held by 53 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 20,796,660 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, Redmile Group, LLC, MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, Point72 Asset Management, L.P., VANGUARD GROUP INC, BlackRock Inc., PICTET ASSET MANAGEMENT SA, Candriam S.C.A., and MORGAN STANLEY. This page lists 53 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.